GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (LTS:0JDM) » Definitions » Valuation Rank

IQVIA Holdings (LTS:0JDM) Valuation Rank


View and export this data going back to 2018. Start your Free Trial

What is IQVIA Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

IQVIA Holdings Valuation Rank Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

IQVIA Holdings (LTS:0JDM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (LTS:0JDM) » Definitions » Valuation Rank
Comparable Companies
IDXX A MTD ICLR ILMN LH DGX WAT EXAS RVTY TMO DHR SHSE:603259 XSWX:LONN XPAR:BIM XPAR:ERF ASX:SHL CRL QGEN SZSE:300347
Traded in Other Exchanges
IQV:USA IQV:Mexico QTS:Germany I1QV34:Brazil
Address
2400 Ellis Road, Durham, NC, USA, 27703
Website
https://www.iqvia.com
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.